A Novel Inhibitor of Dengue Virus Replication That Targets the Capsid Protein

Dengue viruses (DENV) infect 50 to 100 million people worldwide per year, of which 500,000 develop severe life-threatening disease. This mosquito-borne illness is endemic in most tropical and subtropical countries and has spread significantly over the last decade. While there are several promising v...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Byrd, Chelsea M., Dai, Dongcheng, Grosenbach, Douglas W., Berhanu, Aklile, Jones, Kevin F., Cardwell, Kara B., Schneider, Christine, Wineinger, Kristin A., Page, Jessica M., Harver, Chris, Stavale, Eric, Tyavanagimatt, Shanthakumar, Stone, Melialani A., Bartenschlager, Ralf, Scaturro, Pietro, Hruby, Dennis E., Jordan, Robert
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2013
נושאים:
Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535982/
https://ncbi.nlm.nih.gov/pubmed/23070172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01429-12
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים